While STAT3 is clearly an integral pathway to tumor growth and invasion, lifting the “brakes” on immune function through STAT3 checkpoint blockade combined with tumor-specific vaccine therapy may show promise for more robust anti-tumor responses [16]. The gene discussed is STAT3; the disease is neoplasm.